Scientists hunt for genetic clues linking gum disease and heart trouble
NCT ID NCT07353606
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at two genetic markers (Cofilin-2 and Lactoferrin) in 84 adults with gum disease, some of whom also have coronary heart disease. Researchers measure changes in these markers and gum health after a standard deep-cleaning dental treatment. The goal is to better understand how genetics may link gum disease and heart disease, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 84 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Nov 2024
- Expected to finish
-
Apr 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patient willing to participate in the study. 2. Male and female patients with the age group of 30 to 65 years. 3. Patient having more than or equal to 10 remaining natural teeth. 4. No history of long-term antibiotic use in past 6 months. Exclusion Criteria: 1. Subjects with systemic conditions such as type I and type II diabetes mellitus, respiratory diseases, renal disease, liver disease, rheumatoid arthritis, allergy, advanced malignancies/neoplasm and HIV infection will be excluded from the present investigation. 2. Subjects on drugs such as corticosteroids or antibiotics within 6 months of investigation or antiepileptic drugs (phenytoin or cyclosporine) having an impact on periodontal tissues will be excluded. 3. Pregnant women (pregnancy may alter the oral flora). 4. Current smokers and individuals who quit smoking less than 6 months. 5. Patients who have undergone periodontal therapy within the previous 6 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic periodontitis (disorder) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Kilpauk medical college and hospital
Chennai, Tamil Nadu, 600095, India
-
Meenakshi Ammal Dental College and hospital
Chennai, Tamil Nadu, 600095, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a pill replace an IV for gum surgery pain relief?
- Can everyday supplements boost gum disease therapy?
- Can pulling a loose tooth and putting it back save it?
- Gum fluid proteins eyed as link between smoking and periodontitis
- Gum fluid holds clues to Behçet's disease puzzle
- Magnifying the fight against gum disease: loupe vs microscope